- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Large Cap High Growth Potential
Swiss Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SDZ | CHF 37.14 | 0.2% | 34.7% | CHF 16.3b | CHF 43.50 | PS1.8x | E34.9% | 1.2% | ||
GALD | CHF 97.00 | 7.5% | n/a | CHF 23.0b | CHF 99.88 | PS6x | E44.6% | n/a | ||
LONN | CHF 531.00 | -0.3% | 50.2% | CHF 38.4b | CHF 636.90 | PE66.9x | E23.4% | 0.8% |
Page 1 of 1